[HCC移植候选人的生存在等待名单上 - 器官利用是否可以改进?]
Michal Cohen-Naftaly1, Rona Simon2, Nir Lubezky3
1Rabin Medical Center, Beilinson Hospital, Petah Tiqwa, Israel.
Harefuah
|November 21, 2024
概括
肝细胞癌 (HCC) 患者优先接受肝移植,导致获得不平等的机会. 以色列的政策变化改善了非HCC移植率,但没有损害HCC患者的结果,尽管HCC患者仍然有更好的等待名单生存率.
科学领域:
- 肝胆道手术是肝胆道的手术.
- 移植手术 移植手术 移植手术
- 在瘤学瘤学.
相关概念视频
Tissue Transplantation
341
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
341
Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284


